Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagy
蛋白多糖对肿瘤血管生成和内皮细胞自噬的调节
基本信息
- 批准号:10818834
- 负责人:
- 金额:$ 6.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AMP-activated protein kinase kinaseAffectAffinityAllograftingAngiogenesis InhibitorsAngiogenic FactorAngiostatic ProteinsAutophagocytosisBindingBiologicalBiologyBreast Cancer cell lineBreast CarcinomaC-terminalCancer BiologyCellsCellular StressChemicalsCommunicationComplexCore ProteinCuesDevelopmentDiseaseEatingEndothelial CellsEndotheliumEnzymesExonsFemaleFibroblast Growth Factor ReceptorsFundingGADD45A geneGene TargetingGeneticGenetic TranscriptionGrantGrowthHAS2 geneHeparan Sulfate ProteoglycanHyaluronanImmunologicsIn VitroIntegrinsKDR geneKnowledgeLaboratoriesLigationLinkMalignant NeoplasmsMediatingMethodologyModalityModelingMolecularMusMutateNamesNeoplasm MetastasisNutrientOxygenPTPN6 geneParentsParkinPathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPhosphorylation SitePhosphotransferasesProtein Tyrosine PhosphataseProteinsProteoglycanRecombinantsRegulationResearchRoleSecond Primary CancersSensitivity and SpecificitySignal TransductionSpecificityStromal CellsTamoxifenTechnologyTestingTimeTransgenic MiceTranslatingTumor AngiogenesisVEGFA geneVascular EndotheliumVascularizationWorkZebrafishadhesion receptoraggressive breast cancerangiogenesisantagonistattenuationcancer cellcell behaviorcellular engineeringclinically relevantcombatconfocal imagingexperimental studygenetic signaturein vivoinducible Creinhibitorinnovationinterdisciplinary approachmTOR InhibitormTOR inhibitionmalignant breast neoplasmmortalitymouse modelmutantnano-stringneoplastic cellneovascularizationnovelnovel therapeuticsnutrient deprivationoverexpressionparacrineperlecanpredict clinical outcomeprogramspromoterreceptorsensortranscriptometranscriptomicstumortumor microenvironmenttumor progressiontumorigenesistumorigenicultra high resolution
项目摘要
Chief among female mortality is the development, progression, and metastasis of aggressive breast cancer. The
bidirectional communication between the neoplastic cells and the tumor microenvironment, which supplies
oxygen and nutrients, is essential for promoting unchecked tumorigenic development, aberrant
neovascularization, and widespread metastasis. Thus, a better understanding of embedded cues and soluble
messages exchanged between these two compartments will prove invaluable for furthering our knowledge of
the pathobiology of cancer and for reliably predicting clinical outcomes.
Our central hypothesis is that endorepellin, a proteolytic fragment of perlecan, a multi-domain heparan sulfate
proteoglycan, exploits a dual-receptor antagonism to preclude endothelial cells from participating in tumor
angiogenesis. This working hypothesis is based on an impactful and promising body of work all generated under
the auspices of this grant. We discovered that: [a] Endorepellin simultaneously ligates, with high affinity,
VEGFR2 and the 2
Engagement of both receptors underscores the exquisite sensitivity and specificity of endorepellin in targeting
the endothelia. [b] Endorepellin triggers co-internalization of VEGFR2 and 2 1 integrin with concurrent
activation of the SHP-1 tyrosine phosphatase and attenuation of VEGFA signaling. [c] Endorepellin induces
endothelial cell autophagy in a Peg3-dependent manner by modulating Beclin 1, LC3, and p62 expression,
processing, and cellular localization. [d] Endorepellin evokes protracted activation of the energy-sensor kinase
AMPK , irrespective of energy levels. Indeed, this regulation is considered non-canonical as AMPK
phosphorylation occurred under nutrient-enriched conditions. [e] Downstream of AMPK , endorepellin evokes
autophagic flux in endothelial cells that mechanistically parallels the mTOR inhibitor, Torin 1. These striking
findings demonstrate that protracted and sustained autophagy is a novel mechanism by which endorepellin
promotes angiostasis, independent of nutrient deprivation. Based on these discoveries, we plan to:
[1] Elucidate the mechanism of endorepellin-evoked endothelial cell stress, autophagy and mitophagy.
[2] Unravel the mechanism by which endorepellin induces autophagic suppression of HAS2.
[3] Generate novel mouse models of tumorigenesis to explain the pro-autophagic and anti-angiogenic programs
activated by endorepellin.
These concerted research aims will enable us to translate our findings, procured with highly innovative mouse
models of stromal autophagy, into clinically relevant paradigms. The discovery of endorepellin-induced
endothelial cell autophagy downstream of dual receptor antagonism will lead to new therapeutic advances that
actively induce autophagy within the tumor microenvironment to combat this devastating disease.
女性死亡率中最主要的是侵袭性乳腺癌的发生、进展和转移。这
肿瘤细胞与肿瘤微环境之间的双向通讯,提供
氧气和营养物质,对于促进不受控制的致瘤性发展、异常发展至关重要
新生血管形成和广泛转移。因此,更好地理解嵌入的线索和可溶性的
这两个隔间之间交换的信息对于加深我们对以下领域的了解将是非常宝贵的:
癌症的病理学并可靠地预测临床结果。
我们的中心假设是内皮素,基底膜聚糖的蛋白水解片段,多结构域硫酸乙酰肝素
蛋白聚糖,利用双受体拮抗作用来阻止内皮细胞参与肿瘤
血管生成。这个工作假设是基于一个有影响力和有前途的工作,所有这些工作都是在
这笔赠款的赞助。我们发现:[a] Endorepellin 同时以高亲和力连接,
VEGFR2 和 2
两种受体的结合强调了内皮素在靶向方面的精致敏感性和特异性
内皮细胞。 [b] Endorepellin 触发 VEGFR2 和 2 1 整合素的共内化,同时
激活 SHP-1 酪氨酸磷酸酶并减弱 VEGFA 信号传导。 [c] 内皮素诱导
通过调节 Beclin 1、LC3 和 p62 表达以 Peg3 依赖性方式实现内皮细胞自噬,
处理和细胞定位。 [d] Endorepellin 引起能量传感器激酶的长期激活
AMPK ,与能量水平无关。事实上,这个规定被认为是非规范的 AMPK
磷酸化发生在营养丰富的条件下。 [e] AMPK 下游,内皮素诱发
内皮细胞中的自噬通量在机制上与 mTOR 抑制剂 Torin 1 相似。这些惊人的
研究结果表明,长期且持续的自噬是内皮素发挥作用的一种新机制。
促进血管抑制,与营养剥夺无关。基于这些发现,我们计划:
[1] 阐明内皮素诱发内皮细胞应激、自噬和线粒体自噬的机制。
[2] 揭示内皮素诱导 HAS2 自噬抑制的机制。
[3] 生成新的肿瘤发生小鼠模型来解释促自噬和抗血管生成程序
由内皮素激活。
这些一致的研究目标将使我们能够转化我们通过高度创新的鼠标获得的发现
基质自噬模型转化为临床相关范例。内皮素诱导的发现
双受体拮抗下游的内皮细胞自噬将带来新的治疗进展
积极诱导肿瘤微环境中的自噬来对抗这种毁灭性的疾病。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Progranulin and EGFR modulate receptor-like tyrosine kinase sorting and stability in mesothelioma cells.
颗粒体蛋白前体和 EGFR 调节间皮瘤细胞中的受体样酪氨酸激酶分选和稳定性。
- DOI:
- 发表时间:2023-08-01
- 期刊:
- 影响因子:0
- 作者:Ventura, Elisa;Belfiore, Antonino;Iozzo, Renato V;Giordano, Antonio;Morrione, Andrea
- 通讯作者:Morrione, Andrea
A role for decorin in improving motor deficits after traumatic brain injury.
核心蛋白聚糖在改善脑外伤后运动缺陷中的作用。
- DOI:10.1016/j.matbio.2023.12.005
- 发表时间:2023-12-01
- 期刊:
- 影响因子:0
- 作者:Kaori Oshima;N. Siddiqui;J. Orfila;Danelle J Carter;Justin Laing;Xiaorui Han;I. Zakharevich
- 通讯作者:I. Zakharevich
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RENATO V. IOZZO其他文献
RENATO V. IOZZO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RENATO V. IOZZO', 18)}}的其他基金
Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagy
蛋白多糖对肿瘤血管生成和内皮细胞自噬的调节
- 批准号:
10439783 - 财政年份:2020
- 资助金额:
$ 6.18万 - 项目类别:
Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagy
蛋白多糖对肿瘤血管生成和内皮细胞自噬的调节
- 批准号:
10186719 - 财政年份:2020
- 资助金额:
$ 6.18万 - 项目类别:
Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagy
蛋白多糖对肿瘤血管生成和内皮细胞自噬的调节
- 批准号:
10634656 - 财政年份:2020
- 资助金额:
$ 6.18万 - 项目类别:
相似国自然基金
线上民宿房东亲和力对房客预定行为的影响机制研究——基于多源异构数据视角
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
估计和解释序列变体对蛋白质稳定性、结合亲和力以及功能的影响
- 批准号:31701136
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
RGS19对嗜酸细胞性食管炎FcεRI信号传导通路的影响及其作用机制的研究
- 批准号:81500502
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
人B组腺病毒纤毛蛋白与DSG2受体亲和力的差异及其对病毒致病力的影响研究
- 批准号:31570163
- 批准年份:2015
- 资助金额:62.0 万元
- 项目类别:面上项目
TNFalpha-OPG相互作用对骨代谢的影响
- 批准号:30340052
- 批准年份:2003
- 资助金额:9.0 万元
- 项目类别:专项基金项目
相似海外基金
Development of caspase-6 inhibitors for treatment of NASH
开发治疗 NASH 的 caspase-6 抑制剂
- 批准号:
10608905 - 财政年份:2023
- 资助金额:
$ 6.18万 - 项目类别:
Assay development for characterization of Adrb3 antagonists as pain therapeutics
Adrb3 拮抗剂作为疼痛治疗药物表征的测定方法开发
- 批准号:
10287083 - 财政年份:2021
- 资助金额:
$ 6.18万 - 项目类别:
Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagy
蛋白多糖对肿瘤血管生成和内皮细胞自噬的调节
- 批准号:
10439783 - 财政年份:2020
- 资助金额:
$ 6.18万 - 项目类别:
Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagy
蛋白多糖对肿瘤血管生成和内皮细胞自噬的调节
- 批准号:
10186719 - 财政年份:2020
- 资助金额:
$ 6.18万 - 项目类别:
The Impact of Oleoylethanolamide on Glucagon-like Peptide-1 Receptor-Mediated Insulin Secretion and Anorectic Potential
油酰乙醇酰胺对胰高血糖素样肽-1 受体介导的胰岛素分泌和厌食电位的影响
- 批准号:
9415800 - 财政年份:2017
- 资助金额:
$ 6.18万 - 项目类别: